Viewing Study NCT01470456


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-04-12 @ 7:35 PM
Study NCT ID: NCT01470456
Status: COMPLETED
Last Update Posted: 2014-11-13
First Post: 2011-11-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of SAR3419 and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module